Tilkynningar fyrirtækja · 13.11.20261 min read
Leqembi® Pen subcutaneous treatment launched in Japan
Staðbundin vélþýðing · Upprunalegt tungumál heimildar
Summary
STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…
Upprunalegt tungumál heimildar: PR Newswire UK — News ReleasesOpna upprunalega tilkynningu →